Key statistics
On Monday, Abcellera Biologics Inc (ABCL:NSQ) closed at 2.95, 26.34% above the 52 week low of 2.34 set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.80 |
---|---|
High | 3.02 |
Low | 2.80 |
Bid | 2.88 |
Offer | 3.06 |
Previous close | 2.76 |
Average volume | 2.45m |
---|---|
Shares outstanding | 295.37m |
Free float | 212.66m |
P/E (TTM) | -- |
Market cap | 815.21m USD |
EPS (TTM) | -0.5999 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
- AbCellera to Present at Upcoming Investor Conferences in December and January
- AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
- AbCellera Reports Q3 2024 Business Results
- AbCellera to Present at Upcoming Investor Conferences in November 2024
- AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
- AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
- AbCellera to Present at Upcoming Investor Conferences in September
More ▼